Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Contaminated Sites and Indigenous Peoples in Canada and the United States: A Scoping Review

View ORCID ProfileKatherine Chong, View ORCID ProfileNiladri Basu
doi: https://doi.org/10.1101/2022.08.08.22278551
Katherine Chong
1Center for Indigenous Peoples’ Nutrition and Environment, Faculty of Agricultural and Environmental Sciences, McGill University, Ste-Anne-de-Bellevue, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katherine Chong
Niladri Basu
1Center for Indigenous Peoples’ Nutrition and Environment, Faculty of Agricultural and Environmental Sciences, McGill University, Ste-Anne-de-Bellevue, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niladri Basu
  • For correspondence: niladri.basu{at}mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Indigenous communities in Canada and the US are disproportionately exposed to contaminated sites, often arising from industrial and waste disposal activities. For instance, ∼34% of US EPA Superfund sites are of Native American interest, and ∼29% of Canadian federal contaminated sites are on Indigenous reserve land. Contaminated sites pose unique challenges to many Indigenous peoples who consider the land as an integral part of food systems, culture, and the economy. Federal management of contaminated sites is challenged by epistemological differences, regulatory barriers, and minimal scientific research.

Objectives This scoping review aimed to identify and map information on contaminated sites and Indigenous peoples in Canada and the US, namely: 1) the relationship between contaminated sites and Indigenous people, and their land and food systems; 2) strategies, challenges, and successes for contaminated sites assessment and management on Indigenous land; and 3) Indigenous leadership and inclusion in contaminated site assessment and management.

Methods Three streams of data were retrieved from January to March 2022: a systematic literature search (key word groups: Indigenous people and contaminated sites); a grey literature search; and an analysis of federal contaminated site data (Canada’s Federal Contaminated Sites Inventory (FCSI) and US EPA’s Superfund Database).

Results Our search yielded 49 peer-reviewed articles, 20 pieces of grey literature, and 8114 federal site records (1236 Superfund, 6878 FCSI), evidencing the contamination of the lands of 815 distinct Indigenous tribes and nations and the presence of 440 different contaminants or contaminant groups. Minimal information is available on the potential health and ecological effects, assessment and management of risks, and collaboration on contaminated site processes relative to the number of sites on or adjacent to Indigenous lands.

Discussion By integrating three diverse data streams we discovered a multi-disciplinary yet disparate body of information. The results point to a need to prioritize holism, efficiency, and Indigenous leadership in contaminated site assessment, management, and research. This should include a focus on community-specific approaches to site assessment and management; a re-conceptualization of risks related to sites that privileges Indigenous epistemologies; greater collaboration between networks such as the scientific community, Indigenous communities, and federal governments; and a re-evaluation of current management frameworks with Indigenous leadership at the forefront.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We acknowledge funding support to KC from McGill University Faculty of Agricultural and Environmental Sciences (Sustainable Agriculture Fellowship and Graduate Excellence Award) and the PURE CREATE program funded by Natural Sciences and Engineering Research Council of Canada (NSERC). NBs contribution was supported by the Canada Research Chairs (CRC) Program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • DECLARATION OF CONFLICTS OF INTEREST The authors have no conflicts of interest to declare

Data Availability

Data that was analyzed as part of this scoping review is available as a supplemental Excel file and includes data extraction spreadsheets from the peer-reviewed literature and grey literature included, and original data retrieved from the Canadian Federal Contaminated Sites Inventory and Superfund Sites Data repository, which are publically available online (links provided).

https://www.tbs-sct.gc.ca/fcsi-rscf/numbers-numeros-eng.aspx?qid=872789

https://cumulis.epa.gov/supercpad/cursites/srchsites.cfm

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 10, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Contaminated Sites and Indigenous Peoples in Canada and the United States: A Scoping Review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Contaminated Sites and Indigenous Peoples in Canada and the United States: A Scoping Review
Katherine Chong, Niladri Basu
medRxiv 2022.08.08.22278551; doi: https://doi.org/10.1101/2022.08.08.22278551
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Contaminated Sites and Indigenous Peoples in Canada and the United States: A Scoping Review
Katherine Chong, Niladri Basu
medRxiv 2022.08.08.22278551; doi: https://doi.org/10.1101/2022.08.08.22278551

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Toxicology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)